CLINICAL_TRIALS
trial_result
· 2022-01-24
Clinical Trial Update: Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND) [Phase 3]
Summary
Long-term evaluation results from a Phase 3 trial of sarilumab in rheumatoid arthritis have been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2022-01-24